Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Chai brews up $400M series C to fuel AI used by Lilly and Pfizer
Chai Discovery continued its whirlwind emergence, closing its third financing round in less than a year to bring its total haul above $600 million.
Nick Paul Taylor
Jul 14, 2026 10:03am
Fierce Biotech Fundraising Tracker '26: Draig's $65M series B
Jul 14, 2026 5:00am
KKR's Allyntra debuts for medtech industry, announces new CEO
Jul 10, 2026 9:58am
Beeline bolsters autoimmune ambitions with $126M
Jun 30, 2026 7:00am
Talawar heads to Nasdaq via SPAC deal to fund eczema bispecific
Jun 29, 2026 7:00am
Ollin hauls in $330M for Vabysmo challenger's ph. 3 gauntlet
Jun 24, 2026 7:00am
